This Research Topic is part of the 15-Year Anniversary of Cellular Neuroscience Research Topic series, which has been organized in collaboration with the Neuroscience portfolio at Frontiers to celebrate the 15 Year Anniversary of the journal by highlighting some of the most impactful research areas in this field and providing discussion around the latest advances in Glial cell research in relation to schizophrenia and other related disorders as well as new research on this important topic.
By following its mission to freely disseminate high-quality research with a worldwide reach, Frontiers in Non-neuronal cells will continue to play a key role in accelerating the progress of Cellular Neuroscience research and making Open Science a global reality.
This Research Topic article collection focuses on the role of Glial cells in Schizophrenia and related disorders. This is a relatively new and exciting area of research that Frontiers is excited to host a Research Topic on.
The Research Topic welcomes contributions from researchers around the globe in the form of Original Research, Review, Mini Review, and Perspectives focusing on, but not limited to the following subtopics:
• Roles of oligodendrocytes, astrocytes, microglia, and NG2 positive cells in Schizophrenia and related disorders
• Their role as effectors and modulators of neurodevelopment and the mechanisms behind neuron–glial cell interactions
• Genetic and environmental factors affecting glial cells specifically leading to the dysfunctions in supporting neuronal development and functions
• Mechanisms behind alterations at a circuit level and how these can manifest into behavioral characteristics associated with schizophrenia and other related disorders
• New insights into neuroinflammatory processes, and their deleterious effects on the normal brain development
• Investigating possible therapeutic targets for schizophrenia and related disorders through glial cell processes
• Future therapeutic approaches including drugs targeting glial cell functions and if they can have therapeutic effects on schizophrenia
This Research Topic is part of the 15-Year Anniversary of Cellular Neuroscience Research Topic series, which has been organized in collaboration with the Neuroscience portfolio at Frontiers to celebrate the 15 Year Anniversary of the journal by highlighting some of the most impactful research areas in this field and providing discussion around the latest advances in Glial cell research in relation to schizophrenia and other related disorders as well as new research on this important topic.
By following its mission to freely disseminate high-quality research with a worldwide reach, Frontiers in Non-neuronal cells will continue to play a key role in accelerating the progress of Cellular Neuroscience research and making Open Science a global reality.
This Research Topic article collection focuses on the role of Glial cells in Schizophrenia and related disorders. This is a relatively new and exciting area of research that Frontiers is excited to host a Research Topic on.
The Research Topic welcomes contributions from researchers around the globe in the form of Original Research, Review, Mini Review, and Perspectives focusing on, but not limited to the following subtopics:
• Roles of oligodendrocytes, astrocytes, microglia, and NG2 positive cells in Schizophrenia and related disorders
• Their role as effectors and modulators of neurodevelopment and the mechanisms behind neuron–glial cell interactions
• Genetic and environmental factors affecting glial cells specifically leading to the dysfunctions in supporting neuronal development and functions
• Mechanisms behind alterations at a circuit level and how these can manifest into behavioral characteristics associated with schizophrenia and other related disorders
• New insights into neuroinflammatory processes, and their deleterious effects on the normal brain development
• Investigating possible therapeutic targets for schizophrenia and related disorders through glial cell processes
• Future therapeutic approaches including drugs targeting glial cell functions and if they can have therapeutic effects on schizophrenia
